Recent Blog Articles
Seeing red? 4 steps to try before responding
Tics and TikTok: Can social media trigger illness?
Pandemic challenges may affect babies — possibly in long-lasting ways
4 immune-boosting strategies that count right now
If you have knee pain, telehealth may help
How to address opposition in young children
New study investigates treatment-associated regrets in prostate cancer
Minimizing successes and magnifying failures? Change your distorted thinking
Are poinsettias, mistletoe, or holly plants dangerous?
Waiting for motivation to strike? Try rethinking that
Robert C. Meisner, MD
Robert C. Meisner, MD, is the medical director of the ketamine service in the psychiatric neurotherapeutics program at McLean Hospital, and an attending psychiatrist in the acute psychiatric service at Massachusetts General Hospital. He graduated from Princeton summa cum laude and attended Harvard Medical School. He was a doctoral student in cultural anthropology at the Harvard Graduate School for Arts and Sciences, where he focused on child soldiering in Uganda under American anthropologist Arthur Kleinman. He received his early clinical training as a resident at Harvard in internal medicine, anesthesia, critical care, and pain. Dr. Meisner has written and lectured on a wide range of topics, from pediatric and collegiate mood disorders to the safe translation of ketamine research into evidence-based clinical practice. He has previously served on the administrative board of Harvard College, as acting resident dean at Harvard College’s Currier House, and on the faculty of arts and sciences at Harvard University.